TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
0.9800
+0.0550 (5.95%)
At close: Apr 1, 2025, 4:00 PM
0.9999
+0.0199 (2.03%)
After-hours: Apr 1, 2025, 4:37 PM EDT
TherapeuticsMD Revenue
In the year 2024, TherapeuticsMD had annual revenue of $1.76M with 35.25% growth. TherapeuticsMD had revenue of $667.00K in the quarter ending December 31, 2024, with 32.87% growth.
Revenue (ttm)
$1.76M
Revenue Growth
+35.25%
P/S Ratio
6.06
Revenue / Employee
$1,761,000
Employees
1
Market Cap
11.30M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.76M | 459.00K | 35.25% |
Dec 31, 2023 | 1.30M | -68.66M | -98.14% |
Dec 31, 2022 | 69.96M | 67.39M | 2,619.12% |
Dec 31, 2021 | 2.57M | -62.30M | -96.03% |
Dec 31, 2020 | 64.87M | 15.23M | 30.67% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
TXMD News
- 5 days ago - TherapeuticsMD Announces Full Year 2024 Financial Results - Business Wire
- 4 months ago - TherapeuticsMD Announces Third Quarter 2024 Financial Results - Business Wire
- 7 months ago - TherapeuticsMD And 2 Other Stocks Under $2 Executives Are Buying - Benzinga
- 8 months ago - TherapeuticsMD Announces Second Quarter 2024 Financial Results - Business Wire
- 11 months ago - TherapeuticsMD Announces First Quarter 2024 Financial Results - Business Wire
- 1 year ago - TherapeuticsMD Announces Full Year 2023 Financial Results - Business Wire
- 1 year ago - TherapeuticsMD Announces Third Quarter 2023 Financial Results - Business Wire
- 1 year ago - TherapeuticsMD Announces Second Quarter 2023 Financial Results - Business Wire